XML 61 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets, Net (Tables)
 12 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in the carrying amount of goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)U.S. PharmaceuticalPrescription Technology SolutionsMedical-Surgical SolutionsInternationalTotal
Balance, March 31, 2020$3,924 $1,540 $2,453 $1,443 $9,360 
Goodwill acquired— — — 5 5 
Acquisition accounting, transfers, and other adjustments— 2 — — 2 
Other changes/disposals(1)— — — (1)
Impairment charges— — — (69)(69)
Foreign currency translation adjustments, net40 — — 156 196 
Balance, March 31, 20213,963 1,542 2,453 1,535 9,493 
Goodwill acquired— — — 5 5 
Foreign currency translation adjustments, net(40)— — (7)(47)
Balance, March 31, 2022$3,923 $1,542 $2,453 $1,533 $9,451 
Schedule of information regarding intangible assets
Information regarding intangible assets is as follows:
March 31, 2022March 31, 2021
(Dollars in millions)Weighted-
Average
Remaining
Amortization
Period
(Years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Customer relationships12$2,777 $(1,691)$1,086 $3,739 $(2,269)$1,470 
Service agreements91,085 (573)512 1,081 (513)568
Pharmacy licenses— — — — 497(244)253
Trademarks and trade names12819 (386)433 925(394)531
Technology1128 (116)12 150(122)28
Other9187 (171)16 254(226)28
Total
$4,996 $(2,937)$2,059 
(1)
$6,646 $(3,768)$2,878 
(1)Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, “Held for Sale.” This amount was included under the caption “Assets held for sale” in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of 2022.